Login to your account

Username *
Password *
Remember Me
RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events.

RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events.

Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial – The Lancet Oncology (free for a limited period)   Commentary on Twitter Our phase III randomized study, published in Lancet Oncology today, showed high-dose steroid didn’t improve SOB and should not be used routinely in pts with lung […]

The post RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events. appeared first on Links Medicus.

Lu 21 fois
Évaluer cet élément
(0 Votes)

About Author

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.